These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36038043)

  • 1. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy.
    Hashemi M; Moosavi MS; Abed HM; Dehghani M; Aalipour M; Heydari EA; Behroozaghdam M; Entezari M; Salimimoghadam S; Gunduz ES; Taheriazam A; Mirzaei S; Samarghandian S
    Pharmacol Res; 2022 Oct; 184():106418. PubMed ID: 36038043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lncRNA H19 Promotes Cell Proliferation by Competitively Binding to miR-200a and Derepressing
    Yang W; Ning N; Jin X
    Biomed Res Int; 2017; 2017():2767484. PubMed ID: 28164117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors.
    Zhang R; Zeng Y; Deng JL
    Clin Exp Med; 2023 Sep; 23(5):1425-1440. PubMed ID: 36484927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
    Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
    Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer.
    Zhang Y; Li H; Lv C; Wu B; Yu Y; Zhong C; Lang Q; Liang Z; Li Y; Shi Y; Zhang J; Xu F; Tian Y
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35920182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA H19-Derived miR-675 Enhances Proliferation and Invasion via RUNX1 in Gastric Cancer Cells.
    Liu G; Xiang T; Wu QF; Wang WX
    Oncol Res; 2016; 23(3):99-107. PubMed ID: 26931432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis.
    Ashrafizadeh M; Gholami MH; Mirzaei S; Zabolian A; Haddadi A; Farahani MV; Kashani SH; Hushmandi K; Najafi M; Zarrabi A; Ahn KS; Khan H
    Life Sci; 2021 Apr; 270():119006. PubMed ID: 33421521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions.
    Entezari M; Taheriazam A; Orouei S; Fallah S; Sanaei A; Hejazi ES; Kakavand A; Rezaei S; Heidari H; Behroozaghdam M; Daneshi S; Salimimoghadam S; Mirzaei S; Hashemi M; Samarghandian S
    Biomed Pharmacother; 2022 Oct; 154():113609. PubMed ID: 36037786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA H19 Impairs Chemo and Radiotherapy in Tumorigenesis.
    Garcia-Padilla C; Lozano-Velasco E; Muñoz-Gallardo MDM; Castillo-Casas JM; Caño-Carrillo S; Martínez-Amaro FJ; García-López V; Aránega A; Franco D; García-Martínez V; López-Sánchez C
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Transcriptome Analysis of Hair Follicle Morphogenesis Reveals That lncRNA-H19 Promotes Dermal Papilla Cell Proliferation through the Chi-miR-214-3p/β-Catenin Axis in Cashmere Goats.
    Zhang Y; Li F; Shi Y; Zhang T; Wang X
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The double-edged sword of H19 lncRNA: Insights into cancer therapy.
    Shermane Lim YW; Xiang X; Garg M; Le MT; Li-Ann Wong A; Wang L; Goh BC
    Cancer Lett; 2021 Mar; 500():253-262. PubMed ID: 33221454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
    Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
    J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.
    Chen MJ; Deng J; Chen C; Hu W; Yuan YC; Xia ZK
    Int J Biochem Cell Biol; 2019 Aug; 113():27-36. PubMed ID: 31102664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter.
    Gao LM; Xu SF; Zheng Y; Wang P; Zhang L; Shi SS; Wu T; Li Y; Zhao J; Tian Q; Yin XB; Zheng L
    J Cell Mol Med; 2019 Sep; 23(9):6411-6428. PubMed ID: 31317666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA H19: A novel oncogene in multiple cancers.
    Yang J; Qi M; Fei X; Wang X; Wang K
    Int J Biol Sci; 2021; 17(12):3188-3208. PubMed ID: 34421359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control.
    Taheriazam A; Bayanzadeh SD; Heydari Farahani M; Mojtabavi S; Zandieh MA; Gholami S; Heydargoy MH; Jamali Hondori M; Kangarloo Z; Behroozaghdam M; Khorrami R; Sheikh Beig Goharrizi MA; Salimimoghadam S; Rashidi M; Hushmandi K; Entezari M; Hashemi M
    Eur J Pharmacol; 2023 Jul; 951():175781. PubMed ID: 37179043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1.
    Ma H; Yuan L; Li W; Xu K; Yang L
    J Cell Biochem; 2018 Nov; 119(10):8325-8335. PubMed ID: 29968942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
    Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
    Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.